Indonesia vs Senegal: Treatment coverage for schistosomiasis
Indonesia
40.5%
in 2024
Senegal
39.7%
in 2024
Indonesia rank
27th
Senegal rank
29th
Treatment coverage for schistosomiasis over time
- Indonesia
- Senegal
How they compare
Indonesia currently reports 40.5% against 39.7% in Senegal, a difference of 0.8%.
The two have swapped places 6 times across 11 shared years of data; in 2013 it was Indonesia ahead.
Indonesia ranks 27th and Senegal ranks 29th of 45 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Indonesia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 42.9% | 40.9% | 2.0% | Indonesia |
| 2020s | 20.3% | 42.9% | 22.6% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Indonesia or Senegal?
- Indonesia, at 40.5% against 39.7% in Senegal as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Indonesia and Senegal?
- 0.8%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Senegal?
- 11 years are reported by both, from 2013 to 2024.
- How do Indonesia and Senegal rank globally for treatment coverage for schistosomiasis?
- Indonesia ranks 27th and Senegal ranks 29th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.